Drug Abuse Testing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Drug Abuse 
Testing Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  l a t es t  repo r t  by  IM ARC Group,  t i t l ed  "Drug  Abuse  Test ing  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032 ,"  t he  g loba l  d rug  abuse  t es t i ng  marke t  s i ze  reached US$  7 . 0  
B i l l i on  in  2023 .
Report A drug  abuse tes t  i s  a  non - invas i ve  ana lys is  o f  b io log ica l  samp les ,  i nc lud ing  
b lood,  ha i r ,  and  u r ine ,  t o  de tec t  t he  p resence  o f  i l l ega l ,  p resc r i p t ion  d rugs  o r  
t he i r  me tabo l i t es .  D rug  abuse  i s  t he  in ten t iona l  use  o f  i l l ega l  subs tances  or  t he  
Highlight and excess ive  use  o f  over - t he -coun te r  (O TC)  med ica t ions  and  presc r ibed  
psychoac t i ve  o r  pe r f o rmance-enhanc ing  subs tances .  
Description Drug abuse tes t ing  he lps  i den t i f y  in fan t s  and  ch i ld ren  a t  r i s k  o f  exposure  to  
i l l ega l  d rugs  and manage  cases  o f  acu te  men ta l  s ta te  and se izu re  in  t he  
emergency  room.  Cur ren t l y ,  i t  f i nds  ex tens ive  app l i ca t ions  i n  spo r t s  
o rgan iza t ions ,  emp loye rs ,  and  fo rens i c  pu rposes  ac ross  the  g lobe .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/d rug -abuse- tes t ing-marke t / reques tsamp le
Report Description
G l o b a l  D r u g  A b u s e  T e s t i n g  M a r k e t  T r e n d s :
T h e  r i s i n g  d r u g  p r o d u c t i o n  a n d  c o n s u m p t i o n  r e p r e s e n t s  t h e  p r i m a r y  f a c t o r  d r i v i n g  t h e  m a r k e t  g r o w t h .  A d d i t i o n a l l y ,  t h e  i n c r e a s i n g  n u m b e r  o f  
i n d i v i d u a l s  c o n s u m i n g  a l c o h o l  a n d  i l l i c i t  d r u g s ,  s u c h  a s  m a r i j u a n a ,  c o c a i n e ,  a n d  o p i o i d s ,  i s  p o s i t i v e l y  i n f l u e n c i n g  m a r k e t  g r o w t h .  M o r e o v e r ,  
d r u g s  s u c h  a s  o p i a t e s ,  c a n n a b i n o i d s ,  c o c a i n e ,  a l c o h o l ,  d i a z e p a m ,  l y s e r g i c  a c i d  d i e t h y l a m i d e  ( L S D ) ,  b a r b i t u r a t e s ,  a m p h e t a m i n e s ,  a n d  k e t a m i n e  
a r e  a b u s e d  f o r  t h e i r  p s y c h o l o g i c a l  i m p a c t ,  n o n - t h e r a p e u t i c  a n d  m e d i c i n a l  u s e s ,  a l o n g  w i t h  o t h e r  p u r p o s e s ,  s u c h  a s  w e i g h t  l o s s  a n d  e n h a n c i n g  
a t h l e t i c  p e r f o r m a n c e .  I n  l i n e  w i t h  t h i s ,  t h e  r i s i n g  d r u g  d e p e n d e n c e  a n d  s u b s t a n c e  u s e  d i s o r d e r  h a s  c a t a l y z e d  m a r k e t  g r o w t h .  B e s i d e s  t h i s ,  d r u g  
a b u s e  c a n  p o s e  s e v e r e  r i s k s  t o  h e a l t h  a n d  s a f e t y  a n d  l o w e r  t h e  m o r a l e  a n d  p r o d u c t i v i t y  o f  i n d i v i d u a l s .  
A s  a  r e s u l t ,  t h e  e s c a l a t i n g  d e m a n d  f o r  d r u g  a b u s e  t e s t i n g  f o r  e m p l o y e e  a n d  j o b  a p p l i c a n t  s c r e e n i n g  t o  e n s u r e  a  s a f e  w o r k p l a c e  i s  p r o p e l l i n g  t h e  
m a r k e t  g r o w t h .  A p a r t  f r o m  t h i s ,  t h e  r i s i n g  d e m a n d  f o r  u r i n e  d r u g  t e s t i n g  d u e  t o  r a p i d  e x p a n s i o n  i n  p a i n  m a n a g e m e n t  a n d  o p i o i d  d e p e n d e n c y  
c l i n i c s  i s  a n o t h e r  m a j o r  g r o w t h - i n d u c i n g  f a c t o r .  F u r t h e r m o r e ,  s e v e r a l  k e y  p l a y e r s  a r e  l a u n c h i n g  a u t o m a t e d  t e s t i n g  a n d  a n a l y s i s  f o r  d r u g  a b u s e  
a n d  a t - h o m e  u s e  k i t s  f o r  i n s t a n t  d r u g  a b u s e  t e s t s ,  t h e r e b y  c o n t r i b u t i n g  t o  t h e  m a r k e t  g r o w t h .  O t h e r  f a c t o r s ,  i n c l u d i n g  i n c r e a s i n g  m o r t a l i t y  d u e  
t o  d r u g s ,  t h e  e m e r g i n g  e - c o m m e r c e  i n d u s t r y ,  t e c h n o l o g i c a l  a d v a n c e m e n t s  i n  d r u g  s c r e e n i n g  o r  t e s t i n g  d e v i c e s ,  a n d  s t r i n g e n t  g o v e r n m e n t  
p o l i c i e s  m a n d a t i n g  d r u g  s c r e e n i n g ,  a r e  a l s o  c r e a t i n g  a  f a v o r a b l e  m a r k e t  o u t l o o k .
L o o k i n g  f o r w a r d ,  I M A R C  G r o u p  e x p e c t s  t h e  m a r k e t  v a l u e  t o  r e a c h  U S $  1 2 . 0  B i l l i o n  b y  2 0 3 2 ,  e x p a n d i n g  a t  a  C A G R  o f  5 . 9 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / d r u g - a b u s e - t e s t i n g - m a r k e t
Breakup by Product:
• Analyzers
o Immunoassays Analyzers
o Chromatographic Devices
o Breath Analyzers
• Rapid Test ing Devices
o Urine Test ing Devices
Report o Oral  F lu id  Test ing Devices
Segmentation • Consumables
• Laboratory Services
 
Breakup by Sample:
• Urine
• Oral  F lu id  (Sal iva)
• Hair
• Breath
• Others
Breakup by End User:
• Hospitals
• Diagnost ic Laboratories
• Forensic Laboratories
• Workplaces
• Others
Report 
Segmentation Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Drägerwerk AG & Co. KGaA
Competitive 
• F. Hoff mann-La Roche AG
Landscape • Laboratory Corporation of America 
Holdings
with Key 
• Omega Laboratories Inc.
Players • Quest Diagnost ics Incorporated
• Siemens AG
• Thermo Fisher Scient ifi c Inc.
• United States Drug Test ing Laboratories 
Inc.
How has the global drug abuse testing market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the global 
drug abuse testing market?
Key 
What are the key regional markets?
Questions 
Answered in What is the breakup of the market based on the product?
the Report
What is the breakup of the market based on the 
sample?
What is the breakup of the market based on the end 
user?
What are the various stages in the value chain of the 
industry?
What are the key driving factors and challenges in the 
industry?
Key 
What is the structure of the global drug abuse testing 
Questions market and who are the key players?
Answered in 
What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  D r u g  A b u s e  T e s t i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     A n a l y z e r s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  I m m u n o a s s a y s  A n a l y z e r s
           6 . 1 . 2 . 2  C h r o m a t o g r a p h i c  D e v i c e s
           6 . 1 . 2 . 3  B r e a t h  A n a l y z e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     R a p i d  T e s t i n g  D e v i c e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
       
           6 . 2 . 2 . 1  U r i n e  T e s t i n g  D e v i c e s
           6 . 2 . 2 . 2  O r a l  F l u i d  T e s t i n g  D e v i c e s
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     C o n s u m a b l e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
    6 . 4     L a b o r a t o r y  S e r v i c e s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  S a m p l e
    7 . 1     U r i n e
Table of         7 . 1 . 1  M a r k e t  T r e n d s        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     O r a l  F l u i d  ( S a l i v a )
Contents         7 . 2 . 1  M a r k e t  T r e n d s        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     H a i r
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     B r e a t h
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O t h e r s
        7 . 5 . 1  M a r k e t  T r e n d s
        7 . 5 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /d ru g -a bus e - t e s t i n g -ma rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: